Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

IRBESARTAN AND HYDROCHLOROTHIAZIDE

HYDROCHLOROTHIAZIDE; IRBESARTAN

Standard Dose
12.5MG;300MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview IRBESARTAN AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 207896 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient HYDROCHLOROTHIAZIDE; IRBESARTAN Form and strength TABLET;ORAL - 12.5MG;300MG Sponsor HISUN PHARM HANGZHOU Submission history Latest submission status date: 2019-02-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview IRBESARTAN AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 207896 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient HYDROCHLOROTHIAZIDE; IRBESARTAN Form and strength TABLET;ORAL - 12.5MG;300MG Sponsor HISUN PHARM HANGZHOU Submission history Latest submission status date: 2019-02-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.